Published in JAMA on April 06, 1994
Lipid Research Clinics Coronary Primary Prevention Trial (CPPT) | NCT00000488
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA (2009) 5.63
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet (2009) 4.63
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol (2009) 1.52
Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol (2004) 1.48
Lipoprotein(a) in coronary heart disease. Is it a risk factor after all? JAMA (1994) 1.40
Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial. Diabetes (1995) 1.24
Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. J Lipid Res (2010) 1.18
Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study. Circulation (2009) 1.16
Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population. Arterioscler Thromb Vasc Biol (2002) 1.05
Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J Nutr (2009) 1.02
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study. J Lipid Res (2011) 1.00
The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J Clin Invest (1997) 0.99
Hypoalbuminaemia--a marker of cardiovascular disease in patients with chronic kidney disease stages II-IV. Int J Med Sci (2008) 0.91
Lipoprotein (A): Better assessor of coronary heart disease risk in south Indian population. Indian J Clin Biochem (2004) 0.91
Ideal cardiovascular health predicts functional status independently of vascular events: the Northern Manhattan Study. J Am Heart Assoc (2015) 0.86
Niacin: another look at an underutilized lipid-lowering medication. Nat Rev Endocrinol (2012) 0.86
Diabetes predicts long-term disability in an elderly urban cohort: the Northern Manhattan Study. Ann Epidemiol (2014) 0.84
Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome. Heart Vessels (2005) 0.83
Lipoprotein(a) in cardiovascular diseases. Biomed Res Int (2012) 0.83
LP(a) phenotypes and levels in angiographically proven coronary heart disease patients and controls. Indian J Clin Biochem (1998) 0.83
The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians. Atherosclerosis (2008) 0.82
Effects of renal replacement therapy on plasma lipoprotein(a) levels. Am J Nephrol (2007) 0.81
The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol (2007) 0.80
Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease. Indian J Clin Biochem (2015) 0.79
Relationship between Lipoprotein(a) and Thyroid Hormones in Hypothyroid Patients. J Clin Diagn Res (2014) 0.78
Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction. Br Heart J (1995) 0.78
Brain arterial aging and its relationship to Alzheimer dementia. Neurology (2016) 0.78
Lipoprotein(a)-clinical aspects and future challenges. Clin Res Cardiol Suppl (2015) 0.77
Hypercholesterolemia and Dyslipidemia. Curr Treat Options Cardiovasc Med (2000) 0.77
Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a). Metabolism (2015) 0.77
Lipids in liver transplant recipients. World J Gastroenterol (2016) 0.76
The relationship between Lp(a) and CVD outcomes: a systematic review. Lipids Health Dis (2016) 0.76
Lipoprotein(a) and cardiovascular risk factors in a cohort of 6-year-old children. The Rivas-Vaciamadrid Study. Eur J Pediatr (2003) 0.76
Correlation analysis between serum lipoprotein (a) and the incidence of aortic valve sclerosis. Int J Clin Exp Med (2015) 0.75
Brain Perivascular Spaces as Biomarkers of Vascular Risk: Results from the Northern Manhattan Study. AJNR Am J Neuroradiol (2017) 0.75
Current perspectives on laboratory markers for the assessment of cardiovascular disease and myocardial damage. Indian J Clin Biochem (1999) 0.75
The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets. J Cardiothorac Vasc Anesth (2015) 0.75
Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a). Sci Rep (2013) 0.75
Brain Arterial Diameters as a Risk Factor for Vascular Events. J Am Heart Assoc (2015) 0.75
The inclusion of stroke in risk stratification for primary prevention of vascular events: the Northern Manhattan Study. Stroke (2011) 0.75
Lipoprotein(a): searching for a function. Trans Am Clin Climatol Assoc (1996) 0.75
Diagnostic performance of various familial hypercholesterolaemia diagnostic criteria compared to Dutch lipid clinic criteria in an Asian population. BMC Cardiovasc Disord (2017) 0.75
Lipoprotein(a) as a predictor of poor collateral circulation in patients with chronic stable coronary heart disease. Braz J Med Biol Res (2017) 0.75
Long-term statin therapy could be efficacious in reducing the lipoprotein (a) levels in patients with coronary artery disease modified by some traditional risk factors. J Thorac Dis (2017) 0.75
Quality of life independently predicts long-term mortality but not vascular events: the Northern Manhattan Study. Qual Life Res (2017) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta (1972) 9.02
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors. N Engl J Med (1992) 8.38
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 6.51
Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA (1993) 4.75
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 4.09
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
Plasmid transfer from Escherichia coli to Bacteroides fragilis: differential expression of antibiotic resistance phenotypes. Proc Natl Acad Sci U S A (1984) 3.85
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest (1972) 3.43
Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol (1986) 3.35
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation (1974) 3.29
Expression in Escherichia coli of cryptic tetracycline resistance genes from bacteroides R plasmids. Plasmid (1984) 3.19
Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost (1993) 3.12
The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol (1976) 3.12
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 3.09
Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem (1969) 2.98
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation (1998) 2.88
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med (1967) 2.86
Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. J Immunol (1988) 2.82
Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med (1993) 2.80
Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation (1980) 2.72
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta (1987) 2.70
The association of education with coronary heart disease mortality in the USSR Lipid Research Clinics Study. Int J Epidemiol (1993) 2.69
Mycobacterium bovis infections in San Diego: a clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine (Baltimore) (1993) 2.59
Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus. J Exp Med (1976) 2.55
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation (1984) 2.41
Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation (1999) 2.39
Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method. Methods Mol Biol (1998) 2.39
Pathogenesis and management of lipoprotein disorders. N Engl J Med (1985) 2.31
Rapid identification of Candida albicans septicemia in man by gas-liquid chromatography. J Clin Invest (1974) 2.29
A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun (1970) 2.24
Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest (1986) 2.21
Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant. J Immunol (1973) 2.18
Body mass index and body girths as predictors of mortality in black and white women. Arch Intern Med (1992) 2.17
Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr (2007) 2.10
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology (1996) 2.00
Homology between clindamycin resistance plasmids in Bacteroides. Plasmid (1984) 2.00
Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study. Ann Epidemiol (1991) 1.98
Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum Mol Genet (2000) 1.94
Lipoprotein metabolism. Adv Lipid Res (1975) 1.90
Familial apolipoprotein E deficiency. J Clin Invest (1986) 1.87
Increased risk of coronary heart disease death in men with low total and low-density lipoprotein cholesterol in the Russian Lipid Research Clinics Prevalence Follow-up Study. Circulation (1993) 1.86
Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation (1992) 1.84
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis (2001) 1.84
Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol (1982) 1.81
A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA (1986) 1.80
Total inhibition of hepatic beta-lipoprotein production in the rat by orotic acid. J Biol Chem (1967) 1.79
Lack of efficacy of a food-frequency questionnaire in assessing dietary macronutrient intakes in subjects consuming diets of known composition. Am J Clin Nutr (2000) 1.76
How reliably can compact chemistry analyzers measure lipids? JAMA (1990) 1.73
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA (1994) 1.71
Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA (1994) 1.70
Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med (1986) 1.70
Declining mortality in coronary heart disease. Arteriosclerosis (1982) 1.70
Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol (1999) 1.68
Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect Immun (1983) 1.68
Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res (1988) 1.67
Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest (1974) 1.66
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 1.65
Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae. J Infect Dis (1980) 1.64
Epidemiology of dental trauma: a review of the literature. Aust Dent J (2000) 1.64
Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem (1999) 1.64
Absence of P-selectin delays fatty streak formation in mice. J Clin Invest (1997) 1.63
Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res (1994) 1.62
Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease. N Engl J Med (1975) 1.61
Neural substrates of facial emotion processing using fMRI. Brain Res Cogn Brain Res (2001) 1.61
Analysis of sugars in bacterial endotoxins by gas-liquid chromatography. Anal Biochem (1969) 1.60
Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol (1996) 1.60
Guidelines for quality assurance in multicenter trials: a position paper. Control Clin Trials (1998) 1.60
On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim Biophys Acta (1973) 1.59
Simple method for culturing anaerobes. Appl Microbiol (1973) 1.58
The evolution of r factor. A study of a "preantibiotic" community in Borneo. N Engl J Med (1970) 1.56
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J Clin Invest (1969) 1.54
Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr (1997) 1.54
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation (1984) 1.54
High density lipoprotein metabolism in man. J Clin Invest (1977) 1.53
Progress in prevention of cardiovascular disease. Prev Med (1978) 1.53
Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects. J Lipid Res (1978) 1.53
Cardiovascular pathology in hyperlipoproteinemia. Anatomic observations in 42 necropsy patients with normal or abnormal serum lipoprotein patterns. Am J Cardiol (1973) 1.52
Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb (1992) 1.52
The relationship between lipids/lipoproteins and atherosclerosis in African Americans and whites: the Atherosclerosis Risk in Communities Study. Ann Epidemiol (1999) 1.50
Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest (1974) 1.50
Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (2000) 1.49
Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res (1987) 1.49
Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA (1995) 1.48